Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis

Brain

Volumn 120, Issue 10, 1997, Pages 1865-1876

  Koepp, M J ^a,b   Labbe C ^a   Richardson, M P ^a,b   Brooks, D J ^a   Van Paesschen, W ^b   Cunningham, V J ^a   Duncan, J S ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Benzodiazepine receptors; Bilateral pathology; Hippocampal sclerosis; Partial volume effect; PET

Indexed keywords

BENZODIAZEPINE RECEPTOR; CARBON 11; FLUMAZENIL;

ADOLESCENT; ADULT; ARTICLE; BRAIN MAPPING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EPILEPTIC FOCUS; FEMALE; HIPPOCAMPUS; HISTOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RECEPTOR BINDING; SCLEROSIS; TEMPORAL LOBE EPILEPSY;

EID: 0030761933     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/120.10.1865     Document Type: Article

References (45)

1. Babb TL, Brown WJ. Pathological findings in epilepsy. In: Engel J Jr, editor. Surgical treatment of the epilepsies. New York: Raven Press, 1987 511-40.
2. Bailey DL. 3D acquisition and reconstruction in positron emission tomography. Ann Nucl Med 1992; 6: 123-30.
3. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10.
4. Burdette DE, Sakurai SY, Henry TR, Ross DA, Pennell PB, Frey KA, et al. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology 1995; 45: 934-41.
5. Cook MJ, Fish DR, Shorvon SD, Straughan K, Stevens JM. Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain 1992; 115: 1001-15.
6. Cunningham VJ, Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab 1993; 13: 15-23.
7. Engel J Jr. Outcome with respect to epileptic seizures. In: Engel J Jr, editor. Surgical treatment of the epilepsies. New York: Raven Press, 1987: 553-71.
8. Free SL, Bergin PS, Fish DR, Cook MJ, Shorvon SD, Stevens JM. Methods for normalization of hippocampal volumes measured with MR. AJNR Am J Neuroradiol 1995; 16: 637-43.
9. Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilbourn MR, Kuhl DE. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann Neurol 1991; 30: 663-72.
10. Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RSJ. Spatial registration and normalization of images. Hum Brain Mapp 1995; 3: 165-89.
11. Hand KS, Bowery NG, Baird VH, Van Paesschen W, Revesz T, Harkness W, et al. Central benzodiazepine receptor autoradiography in hippocampal sclerosis. Br J Pharmacology. In press.
12. Hartigan JA. Clustering algorithms. New York: John Wiley, 1975.
13. Haycock KA, Roth J, Gagnon J, Finzer WF, Soper C. Abacus concepts, StatView. Berkeley (CA): Abacus Concepts, 1992.
14. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr 1979; 3: 299-308.
15. Jack CR Jr, Sharbrough FW, Cascino GD, Hirschorn KA, O'Brien PC, Marsh WR. Magnetic resonance image-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol 1992; 31: 138-46.
16. Jackson GD, Berkovic SF, Tress BM, Kalnins RM, Fabinyi GC, Bladin PF. Hippocampal sclerosis can be reliably detected by magnetic resonance imaging. Neurology 1990; 40: 1869-75.
17. Jackson GD, Connelly A, Duncan JS, Grunewald RA, Gadian DG. Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology 1993a; 43: 1793-9.
18. Jackson GD, Berkovic SF, Duncan JS, Connelly A. Optimizing the diagnosis of hippocampal sclerosis using MR imaging. AJNR Am J Neuroradiol 1993b; 14: 753-62.
19. Johnson EW, de Lanerolle NC, Kim JH, Sundaresan S, Spencer DD, Mattson RH, et al. 'Central' and 'peripheral' benzodiazepine receptors: opposite changes in human epileptogenic tissue. Neurology 1992; 42: 811-5.
20. Koepp MJ, Richardson MP, Brooks DJ, Poline JB, Van Paesschen W, Fristen KJ, et al. Cerebral benzodiazepine receptors in hippocampal sclerosis: an objective in vivo analysis. Brain 1996; 119: 1677-87.
21. 11C-Flumazenil PET, volumetric MRI and pathology in mesial temporal lobe epilepsy. Neurology 1997. In press.
22. Labbé C, Froment JC, Kennedy A, Ashburner J, Cinotti L. Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging. Alzheimer Dis Assoc Disord 1996; 10: 141-70.
23. Leiderman DB, Balish M, Sato S, Kufta C, Reeves P, Gaillard WD, et al. Comparison of PET measurements of cerebral blood flow and glucose metabolism for the localization of human epileptic foci. Epilepsy Res 1992; 13: 153-7.
24. Levesque MF, Nakasato N, Vinters HV, Babb TL. Surgical treatment of limbic epilepsy associated with extrahippocampal lesions: the problem of dual pathology. J Neurosurg 1991; 75: 364-70.
25. Löscher W, Siemes H. Valproic acid increases gamma-aminobutyric acid in CSF of epileptic children. Lancet 1984; 2: 225.
26. Margerison JHM, Corsellis JAN. Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 1966; 89: 499-530.
27. Maziere M, Hantraye P, Prenant C, Sastre J, Comar D. Synthesis of an ethyl 8-fluoro-5,6-dihydro-5-[11C]methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3- carboxylate (RO 15.1788-11C): a specific radioligand for the in vivo study of central benzodiazepine receptors by positron emission tomography. Int J Appl Radiat Isot 1984; 35: 973-6.
28. Meltzer CC, Zubieta JK, Brandt J, Tune LE, Mayberg HS, Frost JJ. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology 1996a; 47: 454-61.
29. Meltzer CC, Zubieta JK, Links JM, Brakeman P, Stumpf MJ, Frost JJ. MR-based correction of brain PET measurements for heterogeneous gray matter radioactivity distribution. J Cereb Blood Flow Metab 1996b; 16: 650-8.
30. Meynert TH. Studien über das pathologisch-anatomische Material der Wiener Irren-Anstalt. Vjschr Psychiat 1868; 2: 381-402.
31. Miller LA, Munoz DG, Finmore M. Hippocampal sclerosis and human memory. Arch Neurol 1993; 50: 391-4.
32. Müller-Gartner HW, Links JM, Prince JL, Bryan RN, McVeigh E, Leal JP, et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab 1992; 12: 571-83.
33. A receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system. J Chem Neuroanat 1990; 3: 59-76.
34. Petroff OAC, Rothman DL, Behar KL, Lamoureux D, Mattson RH. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol 1996; 39: 95-9.
35. Raymond AA, Fish DR, Stevens JM, Cook MJ, Sisodiya SM, Shorvon SD. Association of hippocampal sclerosis with cortical dysgenesis in patients with epilepsy [see comments]. Neurology 1994; 44: 1841-5. Comment in: Neurology 1995; 45: 1947-8.
36. Raymond AA, Fish DR, Stevens JM, Cook MJ, Sisodiya SM, Shorvon SD. Association of hippocampal sclerosis with cortical dysgenesis in patients with epilepsy [see comments]. Neurology 1994; 44: 1841-5. Comment in: Neurology 1995; 45: 1947-8.
37. Richardson MP, Koepp MJ, Brooks DJ, Fish DR, Duncan JS. Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study. Ann Neurol 1996; 40: 188-98.
38. Robb RA, Hanson DP. ANALYZE: a software system for biomedical image analysis. In: First Conference on Visualisation in Biomedical Computing. Atlanta, 1990: 507-18.
39. Rousset OG, Ma Y, Marenco S, Wong DF, Evans AC. In vivo correction method for partial volume effects in positron emission tomography: accuracy and precision. In: Quantification of brain function using PET. Myers R, Cunningham V, Bailey D, Jones T, editors. San Diego: Academic Press, 1996: 158-65.
40. Sloviter RS. The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. [Review]. Ann Neurol 1994; 35: 640-54.
41. Spinks TJ, Jones T, Bailey DL, Townsend DW, Grootonks S, Bloomfield PM, et al. Physical performance of a positron tomograph for brain imaging with retractable septa. Phys Med Biol 1992; 37: 1637-55.
42. Van Paesschen W, Sisodiya S, Connelly A, Duncan JS, Free SL, Raymond AA, et al. Quantitative hippocampal MRI and intractable temporal lobe epilepsy. Neurology 1995; 45: 2233-40.
43. Van Paesschen W, Connelly A, King MD, Jackson GD, Duncan JS. The spectrum of hippocampal sclerosis: a quantitative magnetic resonance imaging study. Ann Neurol 1997; 41:41-51.
44. Wieser HG. The phenomenology of limbic seizures. In: Wieser HG, Speckmann EJ, Engel J Jr, editors. The epileptic focus. London: John Libbey, 1987: 113-36.
45. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993; 17: 536-46.